Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health.

The glycopeptide avoparcin, bacitracin, the macrolides spiramycin and tylosin, and the streptogramin virginiamycin were withdrawn as growth promoters in the European Union between 1995 and 1999 on the basis of the Precautionary Principle. Relevant resistance thereupon diminished among enterococci (the indicator organisms) isolated from animal and human faeces. However, animal enterococci were shown to differ from those that caused human infections, although their resistance genes were sometimes indistinguishable and thus probably have a common origin. Before the ban, human clinical isolates of enterococci resistant to vancomycin or teicoplanin were uncommon in many, but not all, parts of Europe and resistance to quinupristin/dalfopristin in the case of Enterococcus faecium was very rare. After the ban, these resistances increased in prevalence almost universally, to the detriment of human health. Campylobacters, normally susceptible to macrolides, increased in prevalence before and after the ban. Analyses suggest that the added risk to human health from resistance among enterococci and campylobacters selected by growth promoter use is small, whilst the benefit to human health from their use, hitherto largely ignored, might more than counterbalance this.

[1]  Emma L Snary,et al.  Antimicrobial resistance: a microbial risk assessment perspective. , 2004, The Journal of antimicrobial chemotherapy.

[2]  K. Mølbak.  Spread of resistant bacteria and resistance genes from animals to humans--the public health consequences. , 2004, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[3]  H. Deluyker,et al.  A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals. , 2004, The Journal of antimicrobial chemotherapy.

[4]  F. Baquero,et al.  High occurrence and persistence of antibiotic-resistant enterococci in poultry food samples in Portugal. , 2005, The Journal of antimicrobial chemotherapy.

[5]  I. Forrester,et al.  Precaution, Science and Jurisprudence: a Test Case , 2006 .

[6]  T. Chiller,et al.  Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. , 2004, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[7]  T. Wassenaar.  Use of Antimicrobial Agents in Veterinary Medicine and Implications for Human Health , 2005, Critical reviews in microbiology.

[8]  L. A. Cox,et al.  Modeling the relationship between food animal health and human foodborne illness. , 2007, Preventive veterinary medicine.

[9]  K. Mølbak,et al.  Does the use of antibiotics in food animals pose a risk to human health? An unbiased review? , 2004, The Journal of antimicrobial chemotherapy.

[10]  M. Bonten,et al.  Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. , 2006, Current opinion in microbiology.

[11]  J. Turnidge.  Antibiotic use in animals--prejudices, perceptions and realities. , 2003, The Journal of antimicrobial chemotherapy.

[12]  E. Soulsby.  Resistance to antimicrobials in humans and animals , 2005, BMJ : British Medical Journal.

[13]  D. Robinson,et al.  Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  Ron Jones,et al.  Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. , 2003, The Journal of antimicrobial chemotherapy.

[15]  I. Phillips,et al.  Does the use of antibiotics in food animals pose a risk to human health? A reply to critics , 2004 .

[16]  L. A. Cox.  Potential human health benefits of antibiotics used in food animals: a case study of virginiamycin. , 2005, Environment international.

[17]  T. Barrett,et al.  CDC studies incorrectly summarized in 'critical review'. , 2004, The Journal of antimicrobial chemotherapy.

[18]  Moez Sanaa,et al.  Review of the Community Summary Report on Trends and Sources of Zoonoses, Zoonotic agents and Antimicrobial Resistance in the European Union in 2005 Scientific Opinion of the Scientific Panel on Biological Hazards (BIOHAZ) and Animal Health and Welfare (AHAW) , 2007 .

[19]  B. Karp,et al.  Comment on: Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. , 2004, The Journal of antimicrobial chemotherapy.

[20]  P. Collignon.  Antibiotic growth promoters. , 2004, The Journal of antimicrobial chemotherapy.

[21]  Nicole,et al.  Molecular Diversity and Evolutionary Relationships of Tn1546-Like Elements in Enterococci from Humans and Animals , 1999, Antimicrobial Agents and Chemotherapy.

[22]  I. Phillips,et al.  The susceptibility to growth-promoting antibiotics of Enterococcus faecium isolates from pigs and chickens in Europe. , 2005, Journal of Antimicrobial Chemotherapy.

[23]  L. Tollefson.  Factual errors in review article. , 2004, The Journal of antimicrobial chemotherapy.

[24]  S. Russell,et al.  The effect of airsacculitis on bird weights, uniformity, fecal contamination, processing errors, and populations of Campylobacter spp. and Escherichia coli. , 2003, Poultry science.

[25]  Dominique L. Monnet,et al.  In Vivo Transfer of the vanA Resistance Gene from an Enterococcus faecium Isolate of Animal Origin to an E. faecium Isolate of Human Origin in the Intestines of Human Volunteers , 2006, Antimicrobial Agents and Chemotherapy.

[26]  W. R. Windham,et al.  Effect of intestinal content contamination on broiler carcass Campylobacter counts. , 2004, Journal of food protection.

[27]  C. Drummond,et al.  Conflicts of interest/transparency declarations: new policy. , 2005, The Journal of antimicrobial chemotherapy.

[28]  T. Vartiainen,et al.  Risk-Benefit Analysis of Eating Farmed Salmon , 2004, Science.

[29]  G. Feierl,et al.  Campylobacter jejuni isolated from poultry and humans in Styria, Austria: epidemiology and ciprofloxacin resistance , 2003, Epidemiology and Infection.

[30]  A. Flynn,et al.  Risk-benefit analysis of micronutrients. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[31]  A. van Belkum,et al.  Molecular Diversity and Evolutionary Relationships of Tn1546-Like Elements in Enterococci from Humans and Animals , 1999, Antimicrobial Agents and Chemotherapy.